Sy Mukherjee, Fortune

Sy Mukherjee


New York, NY, United States

Contact Sy

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Learn more here

  • Fortune

Recent articles by Sy:

Here’s Why Biogen Is Forking Over $1.25 Billion to a Small Danish Biotech

Biogen announced Tuesday that it will be paying Copenhagen's Forward Pharma $1.25 billion to protect its best-selling Tecfidera's patent. → Read More

VC Funding for Mobile Health Apps Hit an All-Time Record in 2016

And overall health IT funding crossed the $5 billion threshold. → Read More

Repealing Obamacare Would Take Insurance Away From 32 Million Americans and Double Premiums

Repealing Obamacare without a replacement plan for the law would lead to 32 million more uninsured Americans by 2026, according to CBO. → Read More

Why Trump's Plan to Keep Drug Prices In Check Would Revive 'Death Panel' Politics

You can't have unfettered access and lower prices simultaneously. → Read More

We Just Got a Much Clearer Picture of Marijuana’s Health Effects

Here's what we know about cannabis' benefits and harms. → Read More

Arizona Is Getting Ready to Sue Theranos Over a ‘Long-Running Scheme of Deceptive Acts’

Yet another potential legal headache for Theranos. → Read More

CVS Is Now Selling an EpiPen Competitor at a Massive Discount

CVS is now selling a generic version of the EpiPen competitor Adrenaclick at a fraction of the $600 list price for Mylan's flagship product. → Read More

More Than 100 Biopharma Execs Are Pushing for More Gender Diversity in the Industry

More than 100 major biopharma executives have signed an open letter urging more female participation and recruitment in the life sciences. → Read More

Republicans Balking at a Hasty Obamacare Repeal All Have One Thing in Common

Their constituents are benefiting from a particular provision. → Read More

Biotech Stocks Plunge After Trump Says Pharma Is 'Getting Away With Murder' on Drug Prices

President-elect Donald Trump slammed the pharmaceutical industry's drug pricing in a Wednesday press conference, sending stocks plunging. → Read More

Anti-Vaxxer RFK Jr. Says Trump Asked Him to Chair a Commission on Vaccines

Donald Trump has tapped Robert Kennedy Jr., who's promoted widely debunked vaccine conspiracies, to chair a pane on vaccination safety. → Read More

You Can Now Download an Artificial Intelligence Doctor

Digital health firm HealthTap has launched a service called Dr. A.I. which uses artificial intelligence to assess patient medical symptoms. → Read More

Anthem’s Historic 2015 Health Records Breach Was Likely Ordered by a Foreign Government

The 2015 hack on insurer Anthem which exposed 80 million customer records was likely conducted by a hacker on behalf of a foreign government → Read More

Amgen's Patent Victory Over Sanofi Is 1 of 3 Major IP Cases to Watch

Amgen won a stunning IP victory over Sanofi and Regeneron, whose cholesterol med Praluent was yanked off the market. There's more to come. → Read More

Exclusive: This Digital Health Firm Is Assembling an All-Star Roster of Biopharma Vets

Omada Health is hiring former veteran biopharma execs from Sanofi, Counsyl, and AstraZeneca to boost its diabetes digital therapeutics tech. → Read More

Here's How You Can Prevent Children From Developing Peanut Allergies

Public health experts have released new peanut allergy guidelines, including new recommendations for how to prevent allergies in children. → Read More

This Revolutionary New Tech Uses Light to Activate Medicine

Researchers at UNC-Chapel Hill have developed an experimental method to use long-wave light in order to activate drugs in targeted areas. → Read More

New French Organ Donor Rules Will Make Everyone an Automatic Donor

New regulations in France will make every citizen an organ donor upon death unless they specifically choose to opt out of the system. → Read More

5 Major Trends That Shaped Biopharma's 2016

From drug pricing to CRISPR gene-editing to big data analytics, here are the five trends that defined the biopharma industry's 2016. → Read More

Allergan CEO Brent Saunders Has Had a Historic Record of Biotech Deals

Allergan CEO Brent Saunders has closed a stunning number of biotech deals across the therapeutic spectrum during his time at big pharma. → Read More